Ivy Leaf

Ivy Leaf

Supplement Forms/Alternate Names:

English ivy

Introduction

Ivy leaf is an evergreen vine that grows up walls and trees. It has been used to ease symptoms of cough and bronchitis. It can be taken as a pill, powder, or extract. Ivy leaves can also be made into a syrup or tea.

Dosages

There are no advised doses for ivy leaf.

What Research Shows

Likely Effective

  • Respiratory disease —may ease symptomsB1-B3

Not Enough Data to Assess

Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.

Safety Notes

It is likely safe to take ivy leaf for a short time. Some people may have allergic reactions to the skin.C1, C2 Not enough studies have been done to say whether it is safe to take for a long period or by women who are pregnant or breastfeeding.

Interactions

Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse.

References

A. Bronchial Asthma

A1. Hofmann D, Hecker M, et al. Efficacy of dry extract of ivy leaves in children with bronchial asthma--a review of randomized controlled trials. Phytomedicine. 2003 Mar;10(2-3):213-220.

B. Respiratory Disease

B1. Schmidt M, Thomsen M, et al. Suitability of ivy extract for the treatment of paediatric cough. Phytother Res. 2012 Dec;26(12):1942-1947.

B2. Lang C, Röttger-Lüer P, et al. A valuable option for the treatment of respiratory diseases: review on the clinical evidence of the ivy leaves dry extract EA 575®. Planta Med. 2015 Aug;81(12-13):968-974.

B3. Schaefer A, Kehr MS, et al. A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575®) vs. placebo in the treatment of adults with acute cough. Pharmazie. 2016;71(9):504-509.

C. Safety

C1. Jones JM, White IR, White JM, McFadden JP. Allergic contact dermatitis to English ivy (Hedera helix)--a case series. Contact Dermatitis. 2009 Mar;60(3):179-180.

C2. Gangemi S, Minciullo PL, et al. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 2: Echinacea purpurea-Lavandula angustifolia. Contact Dermatitis. 2015 Apr;72(4):193-205.

Last reviewed February 2020 by EBSCO NAT Review Board Eric Hurwitz, DC
Last Updated: 5/27/2020

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Home |Terms and Conditions |Concerned About Privacy? |Accessibility |Careers |For Employers and Medical Plan Providers

You may also be looking for: CVS/pharmacy | MinuteClinic | Specialty Pharmacy | SilverScript | Accordant